Free Trial
NASDAQ:XRAY

DENTSPLY SIRONA (XRAY) Stock Price, News & Analysis

DENTSPLY SIRONA logo
$16.21 -0.41 (-2.47%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$16.28 +0.07 (+0.41%)
As of 07/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About DENTSPLY SIRONA Stock (NASDAQ:XRAY)

Key Stats

Today's Range
$16.13
$16.44
50-Day Range
$13.37
$16.75
52-Week Range
$12.16
$27.95
Volume
1.21 million shs
Average Volume
2.93 million shs
Market Capitalization
$3.23 billion
P/E Ratio
N/A
Dividend Yield
3.95%
Price Target
$20.36
Consensus Rating
Hold

Company Overview

DENTSPLY SIRONA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

XRAY MarketRank™: 

DENTSPLY SIRONA scored higher than 89% of companies evaluated by MarketBeat, and ranked 115th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on 2 buy ratings, 11 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    DENTSPLY SIRONA has only been the subject of 4 research reports in the past 90 days.

  • Read more about DENTSPLY SIRONA's stock forecast and price target.
  • Earnings Growth

    Earnings for DENTSPLY SIRONA are expected to grow by 3.26% in the coming year, from $1.84 to $1.90 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DENTSPLY SIRONA is -3.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DENTSPLY SIRONA is -3.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    DENTSPLY SIRONA has a PEG Ratio of 1.16. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    DENTSPLY SIRONA has a P/B Ratio of 1.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about DENTSPLY SIRONA's valuation and earnings.
  • Percentage of Shares Shorted

    5.58% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently decreased by 24.46%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    DENTSPLY SIRONA is a leading dividend payer. It pays a dividend yield of 3.95%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    DENTSPLY SIRONA has been increasing its dividend for 13 years.

  • Dividend Sustainability

    Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 33.68% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

  • Read more about DENTSPLY SIRONA's dividend.
  • Percentage of Shares Shorted

    5.58% of the float of DENTSPLY SIRONA has been sold short.
  • Short Interest Ratio / Days to Cover

    DENTSPLY SIRONA has a short interest ratio ("days to cover") of 5.2.
  • Change versus previous month

    Short interest in DENTSPLY SIRONA has recently decreased by 24.46%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    DENTSPLY SIRONA has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for DENTSPLY SIRONA this week, compared to 12 articles on an average week.
  • Search Interest

    Only 1 people have searched for XRAY on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DENTSPLY SIRONA insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.50% of the stock of DENTSPLY SIRONA is held by insiders.

  • Percentage Held by Institutions

    95.70% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DENTSPLY SIRONA's insider trading history.
Receive XRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

XRAY Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

XRAY Stock Analysis - Frequently Asked Questions

DENTSPLY SIRONA's stock was trading at $18.98 on January 1st, 2025. Since then, XRAY stock has decreased by 14.6% and is now trading at $16.21.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) issued its quarterly earnings data on Thursday, May, 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA's revenue for the quarter was down 7.8% on a year-over-year basis.
Read the conference call transcript
.

DENTSPLY SIRONA's board authorized a share repurchase plan on Thursday, November 9th 2023, which allows the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 16.9% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its shares are undervalued.

DENTSPLY SIRONA subsidiaries include these companies: Propel Orthodontics LLC, Datum Dental Ltd., Straight Smile LLC, OraMetrix Inc, Recherche Techniques Dentaires, MIS Implants Technologies Ltd, Sirona Dental System, and others.

DENTSPLY SIRONA's top institutional shareholders include Wealth Enhancement Advisory Services LLC (0.09%), Pallas Capital Advisors LLC (0.04%), Stonebridge Capital Management Inc. (0.02%) and Sivia Capital Partners LLC (0.01%). Insiders that own company stock include Cord Friedrich Staehler, Gregory T Lucier, Glenn Coleman and Eric Brandt.
View institutional ownership trends
.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DENTSPLY SIRONA investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

Company Calendar

Last Earnings
5/08/2025
Record date for 7/11 Dividend
6/27/2025
Ex-Dividend for 7/11 Dividend
6/27/2025
Dividend Payable
7/11/2025
Today
7/13/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:XRAY
CIK
818479
Employees
14,000
Year Founded
1899

Price Target and Rating

High Price Target
$28.00
Low Price Target
$14.00
Potential Upside/Downside
+25.6%
Consensus Rating
Hold
Rating Score (0-4)
2.15
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
8.81
P/E Growth
1.16
Net Income
-$910 million
Net Margins
-24.42%
Pretax Margin
-24.82%
Return on Equity
14.31%
Return on Assets
5.37%

Debt

Debt-to-Equity Ratio
0.79
Current Ratio
1.10
Quick Ratio
0.76

Sales & Book Value

Annual Sales
$3.79 billion
Price / Sales
0.85
Cash Flow
$7.37 per share
Price / Cash Flow
2.20
Book Value
$9.77 per share
Price / Book
1.66

Miscellaneous

Outstanding Shares
199,290,000
Free Float
198,297,000
Market Cap
$3.23 billion
Optionable
Optionable
Beta
0.94

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:XRAY) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners